Nexell Therapeutics Report issue

For profit Phase 1
Founded: Wilmington DE United States (1997)
Status: Defunct (2002)

Organization Overview

First Clinical Trial
1999
NCT00000792
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

hypericin (sgx301) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1